HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norbert Schmitz Selected Research

Vincristine (Oncovin)

2/2022KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials.
4/2021Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial.
1/2021A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
12/2019Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
1/2019Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial.
12/2017PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
10/2016CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.
2/2015Treatment of primary CNS lymphoma.
4/2014Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma.
3/2013MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norbert Schmitz Research Topics

Disease

43Lymphoma (Lymphomas)
01/2022 - 11/2002
26Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2021 - 11/2002
20B-Cell Lymphoma (Lymphoma, B Cell)
02/2022 - 09/2003
20Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2021 - 04/2006
19Neoplasms (Cancer)
02/2022 - 04/2002
18Psychotic Disorders (Schizoaffective Disorder)
07/2022 - 05/2006
17Hodgkin Disease (Hodgkin's Disease)
11/2021 - 06/2002
10Leukemia
03/2016 - 08/2002
10B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2013 - 12/2003
9T-Cell Lymphoma (Lymphoma, T Cell)
01/2022 - 01/2008
9Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2016 - 05/2003
7Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2013
7Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2021 - 01/2004
6Disease Progression
01/2021 - 03/2003
6Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2018 - 11/2004
5Inflammation (Inflammations)
12/2022 - 01/2016
5Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
10/2021 - 06/2007
5Pathologic Complete Response
01/2016 - 04/2004
5Hematologic Neoplasms (Hematological Malignancy)
01/2009 - 06/2003
4Multiple Myeloma
01/2021 - 12/2002
4Prediabetic State (Prediabetes)
12/2018 - 08/2015
4Hypertension (High Blood Pressure)
10/2018 - 12/2002
4Anxiety Disorders (Anxiety Disorder)
01/2017 - 06/2003
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2015 - 03/2003
4Substance-Related Disorders (Drug Abuse)
02/2015 - 05/2006
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2021 - 11/2010
3Acute Promyelocytic Leukemia
01/2020 - 07/2013
3Abdominal Obesity
10/2018 - 01/2016
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2016 - 08/2002
3Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2010 - 05/2007
3Bronchiolitis Obliterans Syndrome
04/2010 - 08/2002
2Obesity
12/2018 - 05/2010
2Mental Disorders (Mental Disorder)
07/2017 - 06/2003
2Mycosis Fungoides
10/2014 - 10/2010
2Central Nervous System Diseases (CNS Diseases)
07/2014 - 04/2009
2Infections
06/2014 - 07/2013
2Graft vs Host Disease (Graft-Versus-Host Disease)
06/2014 - 02/2012
2Schizophrenia (Dementia Praecox)
09/2010 - 01/2009

Drug/Important Bio-Agent (IBA)

26Rituximab (Mabthera)FDA Link
02/2022 - 04/2005
20Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2022 - 11/2002
19Vincristine (Oncovin)FDA LinkGeneric
02/2022 - 11/2002
17Polytetrafluoroethylene (Teflon)FDA Link
07/2022 - 05/2006
17Doxorubicin (Adriamycin)FDA LinkGeneric
02/2022 - 11/2002
15Prednisone (Sone)FDA LinkGeneric
02/2022 - 11/2002
13Etoposide (VP 16)FDA LinkGeneric
04/2021 - 06/2002
10Proteins (Proteins, Gene)FDA Link
11/2020 - 06/2003
6Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021 - 06/2002
5Antipsychotic Agents (Antipsychotics)IBA
07/2022 - 01/2009
5Peptides (Polypeptides)IBA
06/2006 - 06/2003
4Antidepressive Agents (Antidepressants)IBA
01/2021 - 09/2010
4Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 06/2002
4Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2017
4AntigensIBA
02/2012 - 12/2003
4Laminin ReceptorsIBA
06/2011 - 12/2003
3N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA
12/2022 - 10/2018
3Prednisolone (Predate)FDA LinkGeneric
04/2021 - 02/2008
3BI 836826IBA
02/2021 - 10/2020
3Blood Glucose (Blood Sugar)IBA
03/2020 - 01/2012
3Arsenic Trioxide (Trisenox)FDA Link
01/2020 - 07/2013
3Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2020 - 07/2013
3fludarabineIBA
01/2019 - 12/2002
3HDL CholesterolIBA
10/2018 - 01/2016
3Glucose (Dextrose)FDA LinkGeneric
10/2018 - 08/2015
3Methotrexate (Mexate)FDA LinkGeneric
02/2015 - 04/2009
3Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
02/2012 - 12/2002
3Methylphenidate (Ritalin)FDA LinkGeneric
06/2010 - 06/2007
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2009 - 06/2004
3Filgrastim (Neupogen)FDA Link
03/2008 - 08/2002
3SurvivinIBA
06/2006 - 06/2003
3EpitopesIBA
06/2006 - 09/2003
2Dopamine (Intropin)FDA LinkGeneric
10/2021 - 12/2008
2Biological ProductsIBA
01/2021 - 04/2006
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2020 - 11/2002
2SmokeIBA
10/2019 - 08/2015
2Busulfan (Busulfex)FDA Link
01/2019 - 02/2015
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2019 - 01/2013
2Triglycerides (Triacylglycerol)IBA
10/2018 - 01/2016
2Procarbazine (Matulane)FDA Link
12/2017 - 02/2015
2carboxyl radical (COO-)IBA
08/2017 - 11/2011
2ParaffinIBA
08/2017 - 03/2013
22- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2017 - 01/2013
2Neoplasm Antigens (Tumor Antigens)IBA
01/2012 - 06/2006
2IfosfamideFDA LinkGeneric
11/2011 - 03/2008
2Carboplatin (JM8)FDA LinkGeneric
11/2011 - 03/2008
2Cisplatin (Platino)FDA LinkGeneric
11/2011 - 12/2010

Therapy/Procedure

44Stem Cell Transplantation
11/2021 - 06/2002
37Drug Therapy (Chemotherapy)
02/2022 - 06/2002
35Therapeutics
11/2021 - 11/2002
28Transplantation
01/2020 - 06/2002
11Hematopoietic Stem Cell Transplantation
01/2021 - 10/2003
9Homologous Transplantation
01/2022 - 06/2003
8Radiotherapy
12/2019 - 11/2002
7Autologous Transplantation
06/2014 - 03/2003
5Salvage Therapy
11/2021 - 04/2006
5Chemoradiotherapy
03/2016 - 08/2002
4Cell Transplantation
01/2022 - 10/2010
4Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2019 - 08/2002
3Glycemic Control
01/2016 - 06/2003
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
06/2009 - 01/2004
2Combination Drug Therapy (Combination Chemotherapy)
12/2017 - 06/2004